Artesunate Tablets + USP 200 mg + 500 mg + 25 mg Exporter

Artesunate Tablets + USP 200 mg + 500 mg + 25 mg Exporter in India – Healthy Inc

Artesunate Tablets + USP 200 mg + 500 mg + 25 mg Exporter product packaging

Artesunate Tablets + USP 200 mg + 500 mg + 25 mg | Exporter

Product image for Artesunate Tablets + USP 200 mg + 500 mg + 25 mg Exporter; regulatory dossiers & international shipping.

Product Information

Generic NameArtesunate
ManufacturerHealthy Life Pharma Pvt. Ltd.
HSN Code30049099
PharmacopoeiaUSP
Product TypeTablet
CategoryAntimalarial drugs
SubcategoryAntimalarial drugs
Active IngredientArtesunate
Strength200 mg + 500 mg + 25 mg
Dosage FormTablet
Pack Size10 x 10 Tablets / Box (Alu-Alu / Blister)
Route of AdministrationOral
Prescription RequiredYes
Therapeutic CategoryAntimalarial drugs

Medicine Details & Safety

Short DescriptionHealthy Inc invites international procurement enquiries for Artesunate Tablets + USP 200 mg + 500 mg + 25 mg manufactured by Healthy Life Pharma. Importers and overseas distributors can submit destination-country requirements for assessment of registration documentation, export artwork and shipment feasibility.
Approved Uses / Indications1. Acute oral treatment of uncomplicated malaria caused by Plasmodium falciparum. 2. Treatment of mixed Plasmodium infections and chloroquine-resistant malaria strains in endemic regions.
Full Description

Healthy Inc invites international procurement enquiries for Artesunate Tablets + USP 200 mg + 500 mg + 25 mg manufactured by Healthy Life Pharma. Importers and overseas distributors can submit destination-country requirements for assessment of registration documentation, export artwork and shipment feasibility.

Product technical specifications

Generic nameArtesunate
CompositionArtesunate
Strength200 mg + 500 mg + 25 mg
CategoryAntimalarial drugs
PharmacopoeiaUSP
Dosage formTablet

Product technical specifications

Generic nameAcarbose
CompositionAcarbose
Strength25 mg
CategoryAntidiabetic Drugs
PharmacopoeiaUSP / IP
Dosage formTablet

Export regulatory and dossier readiness

Identify the destination authority and registration pathway. Request confirmation of CTD or ACTD dossier availability, COPP, Free Sale Certificate and current GMP documentation as applicable. Confirm COA and analytical files for the proposed product and market.

Climatic zone stability and export artwork

For Artesunate Tablets + USP 200 mg + 500 mg + 25 mg, request stability evidence appropriate to the importing market, including Zone IVb where required. Confirm shelf life, storage conditions and multilingual carton, blister and leaflet artwork against approved documentation.

Global logistics and trade terms

Specify the destination, shipment size and required delivery window. Evaluate air freight or LCL/FCL sea freight from Mumbai where feasible. Agree EXW, FOB, CIF or CIP as appropriate to the transport mode and contract; confirm freight, insurance and customs responsibilities.

International buyer requirements

Enquiries may identify Africa, LATAM, Middle East, CIS or APAC as target regions. Market authorization, import permits, document availability and shipment acceptance must be confirmed for each country; this is not a statement of existing registrations.
Dosage InstructionsAdminister orally with meals or full-fat milk to maximize therapeutic systemic absorption. Take exactly as prescribed for the complete 3-day treatment schedule without missing any doses.
Side EffectsCommon: Headache, dizziness, anorexia, nausea, abdominal discomfort, fatigue. Uncommon: Pruritus, sleep disturbances, palpitation, arthralgia, vomiting. Rare: Cardiac conduction abnormalities (QTc prolongation), hematologic cytopenias.
Warnings and PrecautionsNot for Prophylaxis: Indicated solely for curative therapy of acute uncomplicated malaria. Severe Malaria Alert: If signs of complicated or cerebral malaria emerge, transfer immediately to parenteral therapy. Cardiac Monitoring: Caution in patients with preexisting cardiac arrhythmias.
Contraindications1. Known hypersensitivity to Artesunate or related antimalarial compounds.
2. Severe malaria presenting with coma, severe acidosis, or pulmonary edema.
3. Congenital prolonged QT syndrome or clinically significant cardiac arrhythmias.
Drug Interactions1. Strong CYP3A4 Inducers/Inhibitors: Alter systemic exposure of active antimalarial moieties.
2. QTc-Prolonging Drugs (Antiarrhythmics, Macrolides): Heightened risk of ventricular dysrhythmias.
3. Antiretrovirals: Variable pharmacokinetic interactions; monitor clinical parasitic response.

Frequently Asked Questions

QuestionAnswer
Which registration documents can be requested for Artesunate Tablets + USP 200 mg + 500 mg + 25 mg?Specify CTD/ACTD, COPP, FSC, COA and stability requirements for availability review.
Is Zone IVb data available for Artesunate Tablets + USP 200 mg + 500 mg + 25 mg?Request confirmation for the exact formulation and packaging configuration.
Can export artwork be multilingual for Artesunate Tablets + USP 200 mg + 500 mg + 25 mg?Provide the required languages and approved regulatory artwork for review.
Which shipping terms can be discussed for Artesunate Tablets + USP 200 mg + 500 mg + 25 mg?EXW, FOB, CIF and CIP may be evaluated according to shipment mode and agreement.
How do I obtain an export quotation for Artesunate Tablets + USP 200 mg + 500 mg + 25 mg?Provide destination country, quantity, documentation requirements and preferred trade terms.

Product Tags

Artesunate Tablets + USP 200 mg + 500 mg + 25 mg ExporterArtesunate 200 mg + 500 mg + 25 mgRegulatory Dossiers & International ShippingHealthy Inc

Product Hashtags

#Artesunate#Exporter#PharmaB2B

Related Products

Latest Posts